Vir Biotechnology to Provide Business Update and Report Third Quarter 2024 Financial Results on October 31, 2024
October 17 2024 - 4:30PM
Business Wire
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the
Company will provide a corporate update and report financial
results for the third quarter ended September 30, 2024, on October
31, 2024. The Company will host a conference call at 1:30 p.m.
Pacific Time / 4:30 p.m. Eastern Time on October 31, 2024.
The corporate update and financial results will be provided via
a press release after market close and will be accessible under
Press Releases in the Investors section of the Vir website at
www.vir.bio. Participants may access the conference call via
webcast on the Events & Presentations page of Vir’s website at
https://investors.vir.bio/events-presentations or listen in by
dialing the U.S. toll free number (888) 800-8770 or international
+1 (646) 307-1953. Conference ID: 7568777. A recorded version of
the call will be available on the website approximately two hours
after the completion of the event and will be archived there for 30
days.
About Vir Biotechnology, Inc.
Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical
company focused on powering the immune system to transform lives by
discovering and developing medicines for serious infectious
diseases and cancer. Vir’s clinical-stage portfolio includes
infectious disease programs for chronic hepatitis delta and chronic
hepatitis B infections, in addition to multiple oncology programs.
Vir also has a preclinical portfolio of programs across a range of
other infectious diseases and oncologic malignancies. Vir routinely
posts information that may be important to investors on its
website.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241017372102/en/
Media Arran Attridge Senior Vice President, Corporate
Communications aattridge@vir.bio
Investors Richard Lepke Senior Director, Investor
Relations rlepke@vir.bio
Vir Biotechnology (NASDAQ:VIR)
Historical Stock Chart
From Nov 2024 to Dec 2024
Vir Biotechnology (NASDAQ:VIR)
Historical Stock Chart
From Dec 2023 to Dec 2024